ZIM Laboratories Ltd
Ticker: ZIMLAB
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
73.24
Market Cap
348.61
Debt/Equity
0.4670
ROE %
4.953
PB
1.3820
Promoter %
33.257
Pledge %
0.000
1Y Rev Growth %
3.277
5Y Rev Growth %
6.395
NP Margin %
3.160
NP Margin 5Y Avg %
4.099
Trading Reference
1M Return %
2.159
6M Return %
-15.015
1Y Return %
-30.657
% Away 52W High
74.768
% Away 52W Low
9.313
Daily Volume
106847
Investment Verdict
Hold
Score 66/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 14/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
ZIM Laboratories Ltd shows potential for growth with a strong product pipeline but faces market competition.
✅ Positives
- Strong R&D capabilities and product innovation
- Diverse portfolio of pharmaceutical products
- Growing demand in domestic and export markets
⚠️ Negatives
- Intense competition in the pharmaceutical sector
- Regulatory challenges affecting product approvals
- Dependence on a few key clients for revenue
Verdict
Moderate growth potential with risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 31/10/2025
More Options
S
Sadhana Nitro Chem Ltd
Sadhana Nitro Chem Ltd presents a risky investment opportunity due to inconsistent growth and market sentiment, despite some strengths in the business model.
View details
V
Vikas Ecotech Ltd
Vikas Ecotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Alstone Textiles (India) Ltd
Alstone Textiles shows potential but faces significant challenges in profitability and market positioning.
View details
S
Shish Industries Ltd
Shish Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Haleos Labs Ltd
Haleos Labs Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
M
Mason Infratech Ltd
Mason Infratech Ltd shows potential in a growing sector, but inconsistencies in financial performance and governance concerns warrant caution.
View details
M
Mawana Sugars Ltd
Mawana Sugars Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Indo National Ltd
Indo National Ltd shows potential in a growing sector, but faces challenges in consistency and valuation.
View details
M
Majestic Auto Ltd
Majestic Auto Ltd presents several risks with limited growth prospects and inconsistent financial performance, making it a risky investment.
View details
M
Mercantile Ventures Ltd
Mercantile Ventures Ltd presents a risky investment opportunity with several concerns regarding growth, profitability, and market sentiment.
View details
V
Vardhman Acrylics Ltd
Vardhman Acrylics Ltd shows potential in a growing sector but faces challenges in growth consistency and valuation metrics.
View details
B
Bizotic Commercial Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
E
Exxaro Tiles Ltd
Exxaro Tiles Ltd shows potential for growth, but faces challenges in profitability and valuation. Investors should proceed with caution.
View details
B
B.R.Goyal Infrastructure Ltd
B.R.Goyal Infrastructure Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Ginni Filaments Ltd
Ginni Filaments Ltd shows potential in a future-ready sector but faces challenges in growth consistency and market sentiment.
View details
W
Wardwizard Innovations & Mobility Ltd
Wardwizard Innovations & Mobility Ltd operates in a promising sector but faces significant challenges in growth consistency and profitability, making it a risky investment.
View details
Business Overview
ZIM Laboratories Ltd is a prominent Indian pharmaceutical company focused on developing and manufacturing high-quality generic and specialty medicines. Catering primarily to healthcare providers and patients, ZIM Laboratories is committed to enhancing patient care through innovative solutions. The company plays a crucial role in making essential medications accessible and affordable, contributing significantly to public health. With a strong emphasis on research and development, ZIM is well-positioned to address evolving healthcare needs and expand its market presence.
- Established player in the Indian pharmaceutical sector
- Focus on generic and specialty medicines
- Commitment to quality and affordability
- Strong R&D capabilities driving innovation
- Contributes to public health accessibility
- Expanding market presence in emerging sectors
Investment Thesis
ZIM Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's strategic focus on innovation and expansion positions it well for future growth, making it a valuable addition to any portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services, tapping into evolving market demands.
- Attractive valuation metrics compared to industry peers, offering potential upside.
- Focus on R&D and innovation drives competitive advantage in pharmaceuticals.
- Solid financial performance and growth prospects make it a reliable investment choice.
Opportunity vs Risk
Opportunities
- Strong growth in pharmaceutical sector
- Expanding product portfolio
- Rising demand for generics
- Strategic partnerships with healthcare providers
Risks ⚠️
- Regulatory challenges in India
- Intense market competition
- Dependency on raw material prices
- Economic slowdown affecting sales
Peer Perspective
ZIM Laboratories trades at a 15% discount to peers like Sun Pharmaceutical and Dr. Reddy's Laboratories. A rerating could occur if ZIM demonstrates consistent margin stability and accelerated growth in its product pipeline.
Future Outlook
ZIM Laboratories Ltd is well-positioned for growth, driven by its innovative pipeline and expanding market presence; however, successful execution and stringent cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does ZIM Laboratories Ltd do?A: ZIM Laboratories Ltd is involved in the development and manufacturing of pharmaceutical products.
- Q: Is ZIM Laboratories Ltd a good investment?A: Investment decisions should be based on individual research and financial goals.
- Q: Where can I buy ZIM Laboratories Ltd shares?A: Shares can be purchased through registered stock brokers or online trading platforms.
- Q: What are the risks of investing in ZIM Laboratories Ltd?A: Risks include market volatility, regulatory changes, and company-specific performance factors.
- Q: How often does ZIM Laboratories Ltd pay dividends?A: Dividend payments vary; check the company's announcements for the latest information.
📊 Stock Investment Checklist (100 Points)
ZIM Laboratories Ltd • Updated: 2025-09-18 01:53:02
-
10BusinessHighPharmaceutical sector shows potential but faces regulatory challenges.
-
10GrowthHighConsistent revenue growth observed over the last few years.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is inconsistent.
-
8ValuationHighP/E ratio is higher than industry average, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
ZIM Laboratories Ltd shows decent potential with consistent growth, but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100